NCT05450562
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05450562
Title Dose Escalation and Expansion Study of SAR444200-based Regimen in Adult Participants With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Sanofi
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
USC Norris Comprehensive Cancer Center- Site Number : 8400004 Los Angeles California 90033 United States Details
Icahn School of Medicine at Mount Sinai- Site Number : 8400005 New York New York 10029 United States Details
Lifespan Corporation- Site Number : 8400002 Providence Rhode Island 02903 United States Details
The University of Texas MD Anderson Cancer Center- Site Number : 8400003 Houston Texas 77030 United States Details
Investigational Site Number : 1240002 Toronto Ontario M5G 2M9 Canada Details
Investigational Site Number : 1240001 Québec Quebec G1R 2J6 Canada Details
Investigational Site Number : 1560001 Shanghai 200120 China Details
Investigational Site Number : 1560002 Wuhan 430022 China Details
Investigational Site Number : 7020002 Singapore 119074 Singapore Details
Investigational Site Number : 7020003 Singapore 169610 Singapore Details
Investigational Site Number : 7020001 Singapore 308433 Singapore Details
Investigational Site Number : 4100002 Seoul Seoul-teukbyeolsi 05505 South Korea Details
Investigational Site Number : 4100001 Seoul Seoul-teukbyeolsi 06351 South Korea Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field